Molecular formula: C₅₉H₇₉N1₅O₂₁S₆
Molecular weight:1526.736
Patent period: —
Dositive specifications:–
Injection : —
Oral tablets: —
Injection: —
Molecular formula: C₅₉H₇₉N1₅O₂₁S₆
Molecular weight:1526.736
Patent period: —
Dositive specifications:–
Injection : —
Oral tablets: —
Injection: —
Linaclotide is a potent and selective guanylate cyclase C agonist; Developed for the treatment of constipation-type irritable bowel syndrome (IBS-C) and chronic constipation.
_ LINACLOTIDE
_ LINZEESS
ACTIONS | — |
---|---|
CAS NO. | 851199-59-2 |
FORMULA | C₅₉H₇₉N1₅O₂₁S₆ |
M. WT | 1526.736 |
PURITY | > 98% |
SYNONYMS | Linzees |
STORAGE | — |